NYSE:SYK

Stryker Stock Forecast, Price & News

$262.83
+0.09 (+0.03 %)
(As of 06/23/2021 04:00 PM ET)
Add
Compare
Today's Range
$261.66
$264.26
50-Day Range
$244.76
$267.00
52-Week Range
$171.75
$268.04
Volume61,503 shs
Average Volume1.17 million shs
Market Capitalization$99.02 billion
P/E Ratio71.23
Dividend Yield0.97%
Beta0.96
30 days | 90 days | 365 days | Advanced Chart
Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.


Stryker logo

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

1.90 out of 5 stars

Medical Sector

127th out of 2,105 stocks

Surgical & Medical Instruments Industry

12th out of 174 stocks

Analyst Opinion: 2.3Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Stryker (NYSE:SYK) Frequently Asked Questions

Is Stryker a buy right now?

20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 1 sell rating, 6 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Stryker stock.
View analyst ratings for Stryker
or view top-rated stocks.

What stocks does MarketBeat like better than Stryker?

Wall Street analysts have given Stryker a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Stryker wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Stryker?

Stryker saw a increase in short interest in May. As of May 28th, there was short interest totaling 3,870,000 shares, an increase of 28.1% from the May 13th total of 3,020,000 shares. Based on an average daily volume of 1,120,000 shares, the short-interest ratio is currently 3.5 days. Currently, 1.1% of the shares of the stock are sold short.
View Stryker's Short Interest
.

When is Stryker's next earnings date?

Stryker is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Stryker
.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) issued its quarterly earnings results on Monday, April, 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.99 by $0.06. The medical technology company earned $3.95 billion during the quarter, compared to analyst estimates of $3.94 billion. Stryker had a net margin of 9.57% and a trailing twelve-month return on equity of 21.90%. The company's revenue was up 10.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.84 earnings per share.
View Stryker's earnings history
.

How has Stryker's stock been impacted by COVID-19?

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SYK shares have increased by 49.7% and is now trading at $262.83.
View which stocks have been most impacted by COVID-19
.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker announced a quarterly dividend on Tuesday, May 4th. Shareholders of record on Wednesday, June 30th will be given a dividend of $0.63 per share on Friday, July 30th. This represents a $2.52 annualized dividend and a yield of 0.96%. The ex-dividend date is Tuesday, June 29th.
View Stryker's dividend history
.

Is Stryker a good dividend stock?

Stryker pays an annual dividend of $2.52 per share and currently has a dividend yield of 0.97%. Stryker does not yet have a strong track record of dividend growth. The dividend payout ratio of Stryker is 33.92%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Stryker will have a dividend payout ratio of 24.23% next year. This indicates that Stryker will be able to sustain or increase its dividend.
View Stryker's dividend history.

What guidance has Stryker issued on next quarter's earnings?

Stryker updated its FY 2021 earnings guidance on Tuesday, May, 4th. The company provided earnings per share (EPS) guidance of 9.050-9.300 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.080. The company issued revenue guidance of -.

What price target have analysts set for SYK?

20 analysts have issued 12-month target prices for Stryker's stock. Their forecasts range from $215.00 to $303.00. On average, they anticipate Stryker's share price to reach $268.18 in the next twelve months. This suggests a possible upside of 2.0% from the stock's current price.
View analysts' price targets for Stryker
or view top-rated stocks among Wall Street analysts.

Who are Stryker's key executives?

Stryker's management team includes the following people:
  • Mr. Kevin A. Lobo, Chairman & CEO (Age 56, Pay $2.97M)
  • Mr. Timothy J. Scannell, Pres & COO (Age 56, Pay $1.54M)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 59, Pay $1.28M)
  • Mr. Robert S. Fletcher, VP & Chief Legal Officer (Age 50, Pay $895.89k)
  • Mr. Viju S. Menon, Group Pres of Global Quality & Operations (Age 53, Pay $1.15M)
  • Mr. William E. Berry Jr., VP, Corp. Controller & Principal Accounting Officer (Age 55)
  • Mr. Robert C. Cohen, CTO and VP of Global R&D - Joint Replacement
  • Mr. Alan Douville, VP, Chief Information Officer & Chief Information Security Officer
  • Mr. Preston Wells, VP of Investor Relations
  • Ms. Dana S. McMahon, VP & Chief Compliance Officer

What is Kevin A. Lobo's approval rating as Stryker's CEO?

1,492 employees have rated Stryker CEO Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among Stryker's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Stryker's key competitors?

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), The Walt Disney (DIS), The Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by a number of institutional and retail investors. Top institutional investors include Price T Rowe Associates Inc. MD (7.38%), BlackRock Inc. (6.53%), Greenleaf Trust (5.41%), Bank of New York Mellon Corp (1.96%), Franklin Resources Inc. (1.50%) and Massachusetts Financial Services Co. MA (1.35%). Company insiders that own Stryker stock include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Roch Doliveux, Srikant M Datar and Timothy J Scannell.
View institutional ownership trends for Stryker
.

Which major investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, BlackRock Inc., BlueSpruce Investments LP, Greenleaf Trust, Massachusetts Financial Services Co. MA, State of Michigan Retirement System, Bank of Nova Scotia, and Healthcare of Ontario Pension Plan Trust Fund. Company insiders that have sold Stryker company stock in the last year include Glenn S Boehnlein, Kevin Lobo, M Kathryn Fink, and Timothy J Scannell.
View insider buying and selling activity for Stryker
or view top insider-selling stocks.

Which major investors are buying Stryker stock?

SYK stock was purchased by a variety of institutional investors in the last quarter, including Ameriprise Financial Inc., Nordea Investment Management AB, Oak Ridge Investments LLC, Canada Pension Plan Investment Board, Barclays PLC, Janus Henderson Group PLC, Morgan Stanley, and Flossbach Von Storch AG.
View insider buying and selling activity for Stryker
or or view top insider-buying stocks.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $262.83.

How much money does Stryker make?

Stryker has a market capitalization of $99.02 billion and generates $14.35 billion in revenue each year. The medical technology company earns $1.60 billion in net income (profit) each year or $7.43 on an earnings per share basis.

How many employees does Stryker have?

Stryker employs 43,000 workers across the globe.

Does Stryker have any subsidiaries?

The following companies are subsidiares of Stryker: ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc, Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, CHG Hospital Beds, Cactus LLC, Cardan Robotics, Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, Concentric Medical Inc., Entellus Medical, Entellus Medical Europe Ltd, Entellus Medical Inc., GYS Tech LLC, Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Technology Inc., ITAPCo Limited, Image Guided Technologies, Imorphics Limited, Infinity MSD Corp., Infinity MSE Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Germany GmbH, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Iberia Medcomtech S.L.U., K2M Inc., K2M Solutions Australia Pty Ltd, K2M Spine Solutions (Schweiz) GmbH, K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Hong Kong Ltd, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, OrthoSpace, OrthoSpace Ltd., OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, Patient Safety Technologies, Patton Surgical, Pficonprod Pty. Ltd., Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Czech Sales s.r.o., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Hungary Sales Kft, Physio-Control Inc., Physio-Control India Sales Pvt. Ltd, Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Physio-Control Singapore Pte. Ltd., Physio-Control South Africa Sales Pty. Ltd., Physio-Control UK Sales Ltd., Pivot Medical, PlasmaSol, Porex Technologies, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions BV, Stryker Asia Holdings CV, Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold BV, Stryker Beteiligungs GmbH, Stryker Canada GP ULC, Stryker Canada Holding Company, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Canadian Sales Holding Company ULC, Stryker Capital BV, Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services BV, Stryker Employment Company LLC, Stryker European Coordination Center BV, Stryker European Holdings Coöperatief U.A, Stryker European Holdings I LLC, Stryker European Holdings II LLC, Stryker European Holdings LLC, Stryker European Holdings V LLC, Stryker European Operations B.V., Stryker European Operations Holdings I BV, Stryker European Operations Holdings II BV, Stryker European Operations Holdings III BV, Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker European Technologies C.V., Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France Holding SNC, Stryker France MM Holdings SAS, Stryker France SAS, Stryker Funding B.V., Stryker GI Services CV, Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings BV, Stryker IFSC Designated Activity Company, Stryker Iberia SL Unipersonal, Stryker India Private Limited, Stryker International Acquisitions BV, Stryker International Holdings BV, Stryker Investment Holdings B.V., Stryker Ireland Holding Unlimited Company, Stryker Ireland Limited, Stryker Italia S.r.l. S.U., Stryker Japan Holdings BV, Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Holdings S.a.r.l., Stryker Luxembourg Sarl, Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland BV, Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Limited, Stryker Romania SRL, Stryker Sage Inc., Stryker Sales Corporation, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Trauma GmbH, Stryker Turkish Holdings BV, Stryker UK Ltd, Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TG SP Holdings Corp, TSO3 Corp, TSO3 Inc, Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (BVI) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, VEXIM SA, Vexim, Waterloo Bedding Co., Wright Medical Group, ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.

When was Stryker founded?

Stryker was founded in 1941.

What is Stryker's official website?

The official website for Stryker is www.strykercorp.com.

Where are Stryker's headquarters?

Stryker is headquartered at 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at (269) 385-2600 or via email at [email protected]


This page was last updated on 6/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.